Pharmaceutical compositions comprising epa and a cardiovascular agent and methods of using the same
AssigneeAmarin Pharmaceuticals Ireland Limited
InventorsIan Osterloh, Pierre Wicker, Rene Braeckman, Paresh Soni, Mehar Manku
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to, inter alia, methods of treating mixed dyslipidemia with ethyl eicosapentaenoate.
Claims30
A composition comprising eicosapentaenoic acid and docosahexaenoic acid in free acid form, at least one surfactant and at least one cardiovascular agent.
A method of treating a cardiovascular-related disease in a subject in thereof, the method comprising administering to the subject a therapeutically effective amount of a composition comprising:
- eicosapentaenoic acid, docosahexaenoic acid, at least one surfactant;
- and at least one cardiovascular agent.
The method of claim 17 wherein the cardiovascular-related disease is selected from the group consisting of hyperlipidemia, hypertension, mixed dyslipidemia, and combinations thereof.
The method of claim 31 wherein the dosage units comprise capsules.
Dependencies are inferred from the claim text.